Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Net Margin (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Net Margin for 2 consecutive years, with 39.72% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin rose 18526.0% to 39.72% in Q4 2025 year-over-year; TTM through Dec 2025 was 67.84%, a 8822.0% increase, with the full-year FY2025 number at 67.85%, up 493.0% from a year prior.
  • Net Margin was 39.72% for Q4 2025 at Day One Biopharmaceuticals, up from 49.48% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 38.22% in Q3 2024 to a low of 1372.03% in Q2 2024.